The Oncology Institute (TOI) announced that Gabe Ling has resigned from the Board of Directors, effective December 1, 2025. A formal search process has been initiated to add new independent directors with complementary healthcare, clinical, and value-based care expertise.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TOI:
- Oncology Institute initiated with a Buy at Needham
- Oncology Institute’s Strategic Position and Growth Potential in Value-Based Care Transition
- Oncology Institute, Inc. Reports Robust Q3 Earnings
- Midday Fly By: Walmart names new CEO, Merck acquires Cidara
- Oncology Institute Projects Strong 2025 Revenue Growth